Literature DB >> 13940211

Genitourinary blastomycosis.

L H OPIE, I A TODD, E A ALLEN.   

Abstract

Entities:  

Keywords:  AMPHOTERICIN B; BLASTOMYCOSIS; TUBERCULOSIS, UROGENITAL; URINARY TRACT INFECTIONS

Mesh:

Substances:

Year:  1963        PMID: 13940211      PMCID: PMC1921616     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Therapy with amphotericin B in North American blastomycosis.

Authors:  R S ABERNATHY; G T JANSEN
Journal:  Ann Intern Med       Date:  1960-12-15       Impact factor: 25.391

2.  The modern treatment of North American blastomycosis.

Authors:  J GRANDBOIS
Journal:  Can Med Assoc J       Date:  1958-11-15       Impact factor: 8.262

3.  Genitourinary blastomycosis; case report and review of literature.

Authors:  D ROLNICK; G O BAUMRUCKER
Journal:  J Urol       Date:  1958-02       Impact factor: 7.450

4.  [Eleven cases of North American blastomycosis in Quebec].

Authors:  E GAUMOND
Journal:  Laval Med       Date:  1953-12

5.  Cutaneous and systemic North American blastomycosis.

Authors:  G B ELLIOTT; J C WILT; M DUGGAN
Journal:  Can Med Assoc J       Date:  1952-12       Impact factor: 8.262

6.  A therapeutic dilemma. The treatment of disseminated coccidioidomycosis with amphotericin B.

Authors:  W G SANFORD; J R RASCH; R B STONEHILL
Journal:  Ann Intern Med       Date:  1962-04       Impact factor: 25.391

7.  North American Blastomycosis in the Dog: With a Report of Six Canadian Cases.

Authors:  J Ditchfield; J B Fischer
Journal:  Can Vet J       Date:  1961-03       Impact factor: 1.008

8.  A CASE OF DISSEMINATED BLASTOMYCOSIS.

Authors:  L J Solway; M Kohan; H G Pritzker
Journal:  Can Med Assoc J       Date:  1939-10       Impact factor: 8.262

  8 in total
  1 in total

1.  Blastomycosis: report of three cases from Alberta with a review of Canadian cases.

Authors:  A S Sekhon; M S Bogorus; H V Sims
Journal:  Mycopathologia       Date:  1979-08-31       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.